The global diindolylmethane market size is expected to reach USD 2.3 Billion in 2032 and exhibit considerable growth at a CAGR of 2.9% in the forecast period from 2022 to 2032. The rising popularity of plant-based natural ingredients worldwide is anticipated to bode well for the market. As per Future Market Insights (FMI), the market is likely to be valued at USD 1.6 Billion in 2022.
| Report Attribute | Details |
|---|---|
| Diindolylmethane Market Estimated Base Year Value (2021) | USD 823.3 Million |
| Diindolylmethane Market Expected Market Value (2022) | USD 1.6 Billion |
| Diindolylmethane Market Anticipated Forecast Value (2032) | USD 2.3 Billion |
| Diindolylmethane Market Projected Growth Rate (2022 to 2032) | 2.9% CAGR |
Diindolylmethane is considered to be a natural substance formed in the human body by consuming cruciferous vegetables, such as kale, cauliflower, brussels sprouts, cabbage, and broccoli. It is generated through the acid-catalyzed reaction of indole-3-carbinol.
The extensive usage of diindolylmethane to prevent colorectal, breast, and uterine cancers is anticipated to augment the market. It is also utilized for the treatment of premenstrual syndrome and enlarged prostate.
In addition to that, diindolylmethane is capable of improving and supporting the process of estrogen breakdown by the liver. It also aids in surging the conversion of estrogen of significant metabolites. At the same time, it acts as an aromatase inhibitor to prevent the conversion of testosterone into estrogen.
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
The rising consumption of various health supplements among people to maintain a healthy balance of testosterone in their body is estimated to push sales of diindolylmethane in the global market. Diindolylmethane does not affect the overall testosterone levels while supporting the same.
It possesses multiple properties, such as hormone-balancing, antibacterial, anti-inflammatory, and antiviral, which is also set to drive their demand in future. The increasing usage of diindolylmethane as a therapeutic drug for the treatment of infectious diseases, immune deficiencies, and cancer is another vital factor that is likely to augment growth.
Some of the most common side effects of diindolylmethane include diarrhea, gas, vomiting, nausea, and headache. In some people, the consumption of 600 mg of diindolylmethane every day can lower their sodium levels to a certain extent. These factors may hamper the demand for diindolylmethane in the upcoming years.
Principal Consultant
North America is likely to account for the largest diindolylmethane market share in the evaluation period. The presence of various well-established health supplement manufacturers across the USA and Canada is anticipated to accelerate the regional market.
The increasing prevalence of breast cancer and uterine cancer in these developed countries is another crucial factor that is set to spur the market.
As per the Centers for Disease Control and Prevention (CDC), in 2018, around 254,744 new cases of breast cancer were registered in the USA alone. This number is expected to grow at a fast pace in future years, thereby driving the North America market.
Europe is projected to showcase a steady diindolylmethane market growth in the assessment period. This growth is attributable to the rising purchasing power of consumers and increasing government investments in the development of healthcare infrastructure across the UK, Italy, and Germany.
The rising cases of obesity owing to the rapid adoption of sedentary lifestyle are also anticipated to contribute to this growth. According to the UK Parliament, approximately 28.0% of adults are obese in England, while 36.2% of people are overweight. This trend is likely to continue throughout the forthcoming years, thereby propelling the Europe market.
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
Some of the leading players operating in the global diindolylmethane market include VitaSolutions, Now Health Group, Inc., Genestra Brands, Source Naturals, BioResponse Nutrients, Nature’s Way, Nutri Advanced Ltd., SD Pharmaceuticals, Solaray, Nutricost, Pure Organics, Pure Bulk, Jarrow Naturals, and Adrana LLC among others.
Majority of the key players are focusing on adopting various marketing strategies to increase sales of their in-house products. They are offering their products with several claims, such as soy-free, egg-free, non-GMO, nut-free, corn-free, and organic labels.
A few other companies are engaging in the development of relatively low cost health supplements infused with diindolylmethane to target the middle-class population.
| Report Attribute | Details |
|---|---|
| Growth Rate | CAGR of 2.9% from 2022 to 2032 |
| Base Year for Estimation | 2021 |
| Historical Data | 2015 to 2020 |
| Forecast Period | 2022 to 2032 |
| Quantitative Units | Revenue in USD Million and CAGR from 2022 to 2032 |
| Report Coverage | Revenue Forecast, Volume Forecast, Company Ranking, Competitive Landscape, Growth Factors, Trends and Pricing Analysis |
| Segments Covered | Form, Nature, Source, Region |
| Regions Covered | North America; Latin America; Western Europe; Eastern Europe; APEJ; Japan; Middle East and Africa |
| Key Countries Profiled | USA, Canada, Brazil, Argentina, Germany, UK, France, Spain, Italy, Nordics, BENELUX, Australia & New Zealand, China, India, ASEAN, GCC, South Africa |
| Key Companies Profiled | VitaSolutions; Now Health Group, Inc.; Genestra Brands; Source Naturals; BioResponse Nutrients; Nature’s Way; Nutri Advanced Ltd.; SD Pharmaceuticals; Solaray; Nutricost; Pure Organics; Pure Bulk; Jarrow Naturals; Adrana LLC |
| Customization | Available Upon Request |
The global diindolylmethane market is anticipated to surpass USD 2.3 Billion in 2032.
North America is set to lead the diindolylmethane market in the forecast period.
VitaSolutions, Now Health Group, Inc., Genestra Brands, Source Naturals, BioResponse Nutrients, Nature’s Way, and Nutri Advanced Ltd. are some of the renowned companies in the diindolylmethane market.
1. Executive Summary 2. Market Overview 3. Market Background 4. Global Diindolylmethane Market Analysis 2017 to 2021 and Forecast, 2022 to 2032 5. Global Diindolylmethane Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By Source 5.1. Broccoli 5.2. Kale 5.3. Cauliflower 5.4. Other Sources 6. Global Diindolylmethane Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By Nature 6.1. Organic 6.2. Conventional 7. Global Diindolylmethane Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By Form 7.1. Dry 7.2. Liquid 8. Global Diindolylmethane Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By Sales Channel 8.1. Hospital Pharmacies 8.2. Drug Stores 8.3. Retail Pharmacies 8.4. Online Pharmacies 9. Global Diindolylmethane Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By Region 9.1. North America 9.2. Latin America 9.3. Europe 9.4. East Asia 9.5. South Asia & Pacific 9.6. MEA 10. North America Diindolylmethane Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By Country 11. Latin America Diindolylmethane Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By Country 12. Europe Diindolylmethane Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By Country 13. East Asia Diindolylmethane Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By Country 14. South Asia & Pacific Diindolylmethane Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By Country 15. MEA Diindolylmethane Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By Country 16. Key Countries Diindolylmethane Market Analysis 17. Market Structure Analysis 18. Competition Analysis 18.1. Now Foods 18.2. Source Naturals 18.3. Nature’s Way 18.4. Nutricost 18.5. Genestra Brands 18.6. Pure Bulk 18.7. Jarrow Naturals 18.8. Solaray 18.9. BioResponse Nutrients 18.10. Nutri Advanced 18.11. Pure Organics 19. Assumptions & Acronyms Used 20. Research Methodology
Explore Food and Beverage Insights
View Reports
Diindolylmethane Market
